Detalhe da pesquisa
1.
Peginterferon Beta-1a Shows Antitumor Activity as a Single Agent and Enhances Efficacy of Standard of Care Cancer Therapeutics in Human Melanoma, Breast, Renal, and Colon Xenograft Models.
J Interferon Cytokine Res
; 37(1): 20-31, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27835061
2.
A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activity.
MAbs
; 3(3): 273-88, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21393993